Discordance of Histological Grade between Primary and Metastatic Neuroendocrine Carcinoma

被引:0
|
作者
Adesoye, T. [1 ]
Daleo, M. A. [1 ]
Weber, S. M. [1 ]
Winslow, E. [1 ]
Loeffler, A. G. [1 ]
Cho, C. [1 ]
机构
[1] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 50 条
  • [21] Metastatic primary hepatic neuroendocrine carcinoma. A case report
    Izzo, Paolo
    Izzo, Luciano
    D'Oghia, Giuliano
    Macci, Leonardo
    Gancontieri, Paola
    Codacci-Pisanelli, Massimo
    De Intinis, Claudia
    Izzo, Sara
    ANNALI ITALIANI DI CHIRURGIA, 2023, 12 : 1 - 3
  • [22] Primary Neuroendocrine Carcinoma of the Breast Metastatic to the Bones, Which Chemotherapy?
    Soe, Aye M.
    Joseph, Gardith
    Guevara, Elizabeth
    Xiao, Philip
    BREAST JOURNAL, 2017, 23 (05): : 589 - 593
  • [23] Discordance rate of PD-L1 expression between primary and metastatic lesions in urothelial carcinoma (UC).
    Burgess, Earle Frederick
    Naso, Caroline
    Doherty, Shannon
    Guerrieri, Renato
    Livasy, Chad
    Hartman, Aaron
    Robinson, Myra M.
    Symanowski, James Thomas
    Grigg, Claud
    Graham, David L.
    Osei-Boateng, Kwabena
    Riggs, Stephen Boyd
    Clark, Peter
    Raghavan, Derek
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [24] Metastatic high-grade neuroendocrine carcinoma of unknown primary: Successful treatment in a child with extensive bone marrow involvement
    Bamme, Yevgeniya
    Dandekar, Smita
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [25] AN OBSERVATION OF DNA PLOIDY, HISTOLOGICAL GRADE, AND IMMUNOREACTIVITY FOR TUMOR-RELATED ANTIGENS IN PRIMARY AND METASTATIC BREAST-CARCINOMA
    HITCHCOCK, A
    ELLIS, IO
    ROBERTSON, JFR
    GILMOUR, A
    BELL, J
    ELSTON, CW
    BLAMEY, RW
    JOURNAL OF PATHOLOGY, 1989, 159 (02): : 129 - 134
  • [26] Sensitivity of Octreoscan in neuroendocrine tumours and its association with primary site and histological tumour grade
    Nowosinska, E. J. A.
    Navalkissoor, S.
    Caplin, M.
    Quigley, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S379 - S379
  • [27] Are all Metastatic Grade 3 WHO 2010 Neuroendocrine Carcinoma Poorly Differentiated?
    Velayoudom-Cephise, F. L.
    Duvillard, P.
    Malka, D.
    Leboulleux, S.
    Guigay, J.
    De Baere, T.
    Schlumberger, M.
    Scoazec, J. Y.
    Ducreux, M.
    Baudin, E.
    NEUROENDOCRINOLOGY, 2012, 96 : 66 - 67
  • [28] Lack of UV-Signature Mutations Distinguishes Primary Salivary High-Grade Neuroendocrine Carcinoma from Metastatic Merkel Cell Carcinoma
    Sun, Lulu
    Lewis, James S.
    Duncavage, Eric J.
    Chernock, Rebecca
    MODERN PATHOLOGY, 2018, 31 : 487 - 487
  • [29] Lack of UV-Signature Mutations Distinguishes Primary Salivary High-Grade Neuroendocrine Carcinoma from Metastatic Merkel Cell Carcinoma
    Sun, Lulu
    Lewis, James S.
    Duncavage, Eric J.
    Chernock, Rebecca
    LABORATORY INVESTIGATION, 2018, 98 : 487 - 487
  • [30] A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
    Arlene Chan
    Adrienne Morey
    Belinda Brown
    Diana Hastrich
    Peter Willsher
    David Ingram
    BMC Cancer, 12